Most importantly, we demonstrate that MMP3 can be inhibited by the YAP/TAZ inhibitor verteporfin, which has entered clinical trials as a treatment for pancreatic cancer and glioma [58,59]. This evidence concerns the gene MMP3 and familial pancreatic carcinoma.